Inflammatory Myofibroblastic Tumor — Trials

Inflammatory Myofibroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02180867	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	completed	Phase 2 / Phase 3	140	National Cancer Institute (NCI)NIH	3	Jun 17, 2026	clinicaltrials
NCT05160922	Crizotinib Continuation Clinical Study	active not recruiting	Phase 4	27	PfizerINDUSTRY	5	Mar 30, 2026	clinicaltrials
NCT04925609	Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors(Briga-PED)	recruiting	Phase 1 / Phase 2	65	Princess Maxima Center for Pediatric OncologyOTHER	2	Dec 5, 2025	clinicaltrials
NCT04260009

Data updated 22 days agoSource updated Jun 17, 2026source: clinicaltrials